Identification of Extrachromosomal Circular DNA Isolated from Cell Culture Supernatant and Its Potential Applications for Hepatocellular Carcinoma Diagnosis

Document Type : Research Articles

Authors

1 Division of Research and Technology Assessment, National Cancer Institute, Bangkok, Thailand.

2 Institute of Molecular Biosciences, Mahidol University, Salaya, Nakhon Pathom, Thailand.

3 National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Bangkok, Thailand.

4 Division of Biological Science, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla, Thailand.

Abstract

Background: Hepatocellular carcinoma (HCC) is the most common primary liver malignancy worldwide and is associated with a high mortality rate. The unique genetic features and structural properties of extrachromosomal circular DNA (eccDNA) offer a promising approach for early cancer diagnosis. Objective: This study aims to investigate the potential of eccDNA as a diagnostic marker by identifying its distinguishing characteristics using a two-dimensional cell culture model. Methods: EccDNA was isolated from the supernatant of HepG2 and THLE-2 cell cultures. Long-read sequencing and bioinformatic analysis were employed to detect and characterize eccDNA. The size distribution, chromosomal origin, and genomic annotation of eccDNA from both cell types were compared. PCR was performed to validate DNA fragments at the junctions of the closed-circular forms. Results: The total number of cell-free eccDNA derived from HepG2 cells averaged 2,669,673 bases, encompassing 2,542 sequences, while THLE-2 cells averaged 857,718 bases with 975 sequences. Size distribution analysis revealed that most cell-free eccDNA from both cell types ranged from 351 to 600 bp. Bioinformatic analysis revealed that approximately 80% of eccDNAs corresponded to gene coding regions. Ten eccDNAs were the most frequently detected in HepG2 cells, with four eccDNAs harboring CDC27P11, RAC1P3, LOC112268123, and LOC124902279 genes successfully validated and uniquely detected in HepG2 cells, suggesting their potential as biomarkers for HCC diagnosis. Conclusion: Distinct eccDNA types were identified in HepG2 cells, which may serve as promising biomarkers for HCC diagnosis.

Keywords

Main Subjects

Asian Pacific Journal of Cancer Prevention
Volume 27, Issue 1
January 2026
Pages 97-107

Files

History

  • Receive Date: 25 March 2025
  • Revise Date: 15 August 2025
  • Accept Date: 05 January 2026

Share

How to cite

Statistics